« Previous
Next »
Titles
- CardioMEMS (tm) HF System (St. Jude Medical, Inc.) and Sacubitril/Valsartan (Entresto (tm), Novartis AG) for management of congestive heart failure: effectiveness, value, and value-based price benchmarks : final report1
- Controversies in migraine management: a technology assessment : final report1
- Controversies in obesity management: a technology assessment : final report1
- Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value1